Hepatology · Article 193

How Should Autoimmune Hepatitis Be Diagnosed?

Autoimmune hepatitis diagnosis requires a structured, evidence-based clinical approach. This review summarizes the key diagnostic, management, monitoring and decision points for gastroenterology and hepatology practice.

Autoimmune hepatitis diagnosis clinical reference — Related free clinical resource: Guideline-Based Management in Hepatology.

Autoimmune hepatitis diagnosis: practical clinical approach

This page focuses on Autoimmune hepatitis diagnosis with emphasis on decisions that change patient care, common pitfalls, and the current evidence base.

External guidance for Autoimmune hepatitis diagnosis

Clinical takeaway: For Autoimmune hepatitis diagnosis, decisions should integrate current guidelines, patient-specific risk, and the evidence summarized below.

Answer first: Autoimmune hepatitis (AIH) has no single diagnostic test. Diagnosis requires a compatible pattern of liver injury, elevated IgG in many patients, characteristic autoantibodies, exclusion of viral, drug-induced and metabolic causes, and liver biopsy showing interface hepatitis with compatible inflammatory features. ANA and smooth-muscle antibody are common in type 1 AIH; anti-LKM1 is more associated with type 2 disease. A normal IgG or negative ANA does not completely exclude AIH, especially in acute presentations.

Biopsy is central

Histology confirms compatible hepatitis, stages fibrosis and helps distinguish AIH from competing diagnoses.

Serology supports but does not prove disease

Autoantibodies can occur in MASLD, viral hepatitis and healthy individuals.

Acute severe AIH can look different

IgG or autoantibodies may be less impressive, and rapid exclusion of viral/drug causes is important.

Practical clinical algorithm

1. Confirm hepatocellular liver injury.

2. Measure IgG and appropriate autoantibodies.

3. Exclude viral hepatitis, DILI, Wilson disease and other causes as appropriate.

4. Perform liver biopsy unless there is a compelling contraindication.

5. Use simplified AIH scoring only as a support—not a substitute for clinical judgment.

6. Stage fibrosis and assess treatment indication.

Common mistakes to avoid

Diagnosing AIH from ANA positivity alone.
Skipping biopsy in a diagnostically uncertain case.
Assuming normal IgG rules it out.
Ignoring drug-induced autoimmune-like hepatitis.
Failing to exclude viral hepatitis.

Trainee takeaway

AIH is a clinic-serology-histology diagnosis; no single antibody is the disease.

Frequently asked questions

Is ANA required?

No.

Is biopsy always needed?

It is strongly recommended for diagnosis in most patients.

Can AIH present acutely?

Yes, including acute severe hepatitis and rarely acute liver failure.

References

1. Thomson ABR. Guideline-Based Management in Hepatology. CAPstone Academic Publishers; 2015.

2. Thomson ABR. First Principles of Gastroenterology and Hepatology in Adults and Children. 7th ed. CAPstone Academic Publishers; 2013.

3. Mack CL, Adams D, Assis DN, et al. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines from AASLD. Hepatology. 2020;72:671-722.

Educational content only. Clinical decisions should incorporate the individual patient, local resources, product labeling, and the most current applicable guideline or regulatory information.

← Back to Clinical Questions